Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Johnson & Johnson (NYSE:JNJ) and maintained a price target of $215.
October 10, 2024 | 3:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating for Johnson & Johnson, maintaining a price target of $215, indicating confidence in the company's stock performance.
The reiteration of an Overweight rating and a maintained price target of $215 by a reputable analyst suggests a positive outlook for JNJ's stock, likely boosting investor confidence and potentially leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100